Recombinant Human Angiopoietin-2 Protein: Biology & Applications
Recombinant Human Angiopoietin-2 Protein: Biology & Applications
Recombinant Human Angiopoietin-2 Protein is a critical regulator of vascular remodeling and angiogenesis, acting primarily as a context-dependent antagonist or weak agonist of the Tie2 receptor tyrosine kinase and playing essential roles in tumor vasculature, inflammation, and pathological neovascularization research.
- Protein Name
- Recombinant Human Angiopoietin-2 (Ang-2)
- Primary Receptor
- Tie2 (TEK) receptor tyrosine kinase
- Primary Function
- Context-dependent antagonist/weak agonist of Tie2; promotes vascular destabilization and angiogenesis in cooperation with VEGF
- Key Research Areas
- Angiogenesis, tumor vasculature, inflammation, diabetic retinopathy, sepsis
- Expression System
- Typically produced in mammalian or insect expression systems to ensure proper folding and activity
- Product SKU
- rp365010
What Is Angiopoietin-2 and Why Does It Matter?
Angiopoietin-2 (Ang-2, also designated ANGPT2) is a secreted glycoprotein and a member of the angiopoietin family of growth factors, which also includes Angiopoietin-1 (Ang-1), Angiopoietin-3, and Angiopoietin-4. Ang-2 is predominantly expressed by endothelial cells and is stored in Weibel–Palade bodies, enabling rapid release in response to inflammatory or hypoxic stimuli. Its primary signaling target is the Tie2 (TEK) receptor tyrosine kinase expressed on vascular endothelium.
Unlike Ang-1, which acts as a constitutive Tie2 agonist to promote vascular stability and quiescence, Ang-2 functions predominantly as a context-dependent antagonist of Tie2. In the absence of pro-angiogenic signals such as VEGF, Ang-2 can induce vessel regression and endothelial cell apoptosis. In the presence of VEGF, however, Ang-2 cooperates to promote vascular sprouting, remodeling, and pathological neovascularization. This dual nature makes Ang-2 a highly studied target in oncology, inflammatory disease, and metabolic disorders.
Structural Features of Recombinant Human Angiopoietin-2 Protein
Human Angiopoietin-2 is encoded by the ANGPT2 gene and is synthesized as a precursor protein. The mature form contains several functionally important domains: an N-terminal coiled-coil domain responsible for oligomerization and secretion, a linker region, and a C-terminal fibrinogen-related domain (FReD) that mediates high-affinity binding to the Tie2 receptor.
Ang-2 forms higher-order oligomers (dimers and tetramers) through its coiled-coil domain, and the degree of oligomerization can influence its agonistic versus antagonistic activity toward Tie2. Recombinant production requires careful attention to expression system selection to preserve native disulfide bonding, glycosylation patterns, and oligomeric assembly, all of which are critical for biological activity. Mammalian and baculovirus-insect cell expression systems are commonly employed to achieve these post-translational modifications.
Key Research Applications
Recombinant Human Angiopoietin-2 Protein is widely used across multiple research disciplines:
- Angiogenesis assays: Ang-2 is used to stimulate or modulate endothelial tube formation, migration, and sprouting assays in vitro, enabling dissection of pro- and anti-angiogenic signaling pathways.
- Tumor biology: As tumor vasculature is characterized by elevated Ang-2 expression, recombinant Ang-2 is used to model pathological angiogenesis, study pericyte detachment, and evaluate anti-angiogenic therapeutic strategies.
- Inflammation research: Ang-2 sensitizes the endothelium to inflammatory cytokines such as TNF-α, promoting leukocyte adhesion and vascular permeability. Recombinant Ang-2 is employed in models of sepsis, acute lung injury, and cytokine storm.
- Receptor binding and signaling studies: Recombinant Ang-2 is used in surface plasmon resonance (SPR), ELISA-based binding assays, and cell-based Tie2 phosphorylation assays to characterize receptor–ligand interactions and downstream signaling cascades.
- Diabetic retinopathy and ocular neovascularization: Elevated Ang-2 is implicated in retinal microvascular complications; recombinant protein enables mechanistic studies in retinal endothelial cell models.
Handling, Storage, and Quality Considerations
To ensure optimal biological activity and experimental reproducibility, researchers should follow best practices when working with Recombinant Human Angiopoietin-2 Protein:
- Reconstitution: Lyophilized protein should be reconstituted in the carrier solution recommended by the manufacturer (typically sterile PBS containing a carrier protein such as BSA). Allow the vial to equilibrate to room temperature before reconstitution.
- Storage: Aliquot the reconstituted protein immediately to avoid repeated freeze-thaw cycles, which can degrade activity. Store working aliquots at –20 °C or –80 °C as recommended.
- Quality assessment: Confirm protein identity and purity by SDS-PAGE and, where available, by activity in a validated bioassay such as Tie2 phosphorylation or endothelial cell migration assay.
- Endotoxin levels: For cell-based assays, select lots with endotoxin levels below 1 EU/μg protein to minimize confounding inflammatory effects.
- Carrier protein compatibility: If downstream assays are sensitive to BSA or human serum albumin (HSA), request carrier-free formulations.
Why Choose Aladdin Scientific Recombinant Human Angiopoietin-2 Protein?
Aladdin Scientific offers Recombinant Human Angiopoietin-2 Protein (SKU: rp365010) as part of its curated portfolio of research-grade cytokines and growth factors. Key reasons to choose this product include:
- Research-grade quality: Produced and quality-controlled to meet the demands of demanding in vitro and cell biology assays.
- Consistent lot-to-lot performance: Rigorous quality control ensures reproducibility across experiments.
- Dedicated technical support: Aladdin Scientific's scientific team is available to assist with protocol optimization, reconstitution guidance, and application troubleshooting.
- Competitive pricing: High-quality recombinant proteins accessible to academic and industrial research laboratories at competitive price points.
For ordering information, specifications, and current availability, visit the product page for SKU rp365010 or contact Aladdin Scientific customer support.
Frequently asked questions
What is the difference between Angiopoietin-1 and Angiopoietin-2?
Angiopoietin-1 (Ang-1) is a constitutive Tie2 agonist that promotes vascular stability, endothelial quiescence, and pericyte recruitment. Angiopoietin-2 (Ang-2) is predominantly a context-dependent Tie2 antagonist: in the absence of VEGF it can cause vessel regression, while in the presence of VEGF it promotes angiogenic sprouting and vascular remodeling. Ang-2 is also stored in endothelial Weibel–Palade bodies for rapid release, whereas Ang-1 is primarily secreted by supporting cells such as pericytes and smooth muscle cells.
What expression system is used to produce Recombinant Human Angiopoietin-2 Protein?
Recombinant Human Angiopoietin-2 is typically produced in mammalian cell expression systems (such as HEK293 or CHO cells) or baculovirus-infected insect cell systems to ensure correct disulfide bond formation, glycosylation, and native oligomeric assembly required for full biological activity. Researchers should confirm the specific expression system used with the product datasheet to ensure compatibility with their assay requirements.
How should Recombinant Human Angiopoietin-2 Protein be stored to maintain activity?
Lyophilized Recombinant Human Angiopoietin-2 should be stored at –20 °C or –80 °C and protected from moisture. Upon reconstitution, the protein should be aliquoted immediately and stored at –80 °C. Repeated freeze-thaw cycles should be strictly avoided, as they can significantly reduce biological activity. Always consult the specific product datasheet for manufacturer-recommended storage conditions and shelf life.
Can Recombinant Human Angiopoietin-2 be used to study tumor angiogenesis?
Yes. Ang-2 is significantly upregulated in the tumor microenvironment and plays a key role in destabilizing existing vessels to permit angiogenic sprouting in cooperation with VEGF. Recombinant Human Angiopoietin-2 Protein is widely used in co-stimulation experiments with VEGF, in vitro tube formation and migration assays with tumor-associated endothelial cells, and in evaluating neutralizing antibodies or small-molecule inhibitors targeting the Ang-2/Tie2 axis.
What assays can be used to verify the activity of Recombinant Human Angiopoietin-2 Protein?
Biological activity of Recombinant Human Angiopoietin-2 can be assessed by several assays, including Tie2 phosphorylation assays using human umbilical vein endothelial cells (HUVECs), endothelial cell migration or tube formation assays, and receptor-binding assays such as ELISA or surface plasmon resonance (SPR) measuring affinity for recombinant Tie2 extracellular domain. Purity and integrity should additionally be confirmed by SDS-PAGE under reducing and non-reducing conditions.
References
- Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nature Reviews Molecular Cell Biology. 2009;10(3):165-177. doi:10.1038/nrm2639
- Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends in Immunology. 2006;27(12):552-558. doi:10.1016/j.it.2006.10.004
- Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277(5322):55-60. doi:10.1126/science.277.5322.55
- Thurston G, Daly C. The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway. Cold Spring Harbor Perspectives in Medicine. 2012;2(9):a006550. doi:10.1101/cshperspect.a006550
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)